Breast Cancer
News
Eribulin Extends Survival of Women With Heavily Pretreated Breast Cancer
Major Finding: Median overall survival rate reached 13.1 months in women treated with eribulin, compared with 10.6 months in the control group (P...
News
Trastuzumab Benefit Persists at 4 Years in HER2-Positive Breast Cancer
Major Finding: Disease-free survival at a median follow-up of 48.4 months in 1,703 women initially randomized to receive 1 year of treatment with...
News
FDA Grants Hearing on Withdrawal of Bevacizumab Approval
News
Letter - Acneiform Rash as a Reaction to Radiotherapy in a Breast Cancer Patient
News
Cost–Utility Analysis of Palonosetron-Based Therapy in Preventing Emesis Among Breast Cancer Patients
Article
Retrospective analysis of communication with patients undergoing radiological breast biopsy
Video
Radiation After Lumpectomy Reduced Mortality, Recurrence Risk
News
Can nonhormonal treatments relieve hot flushes in breast Ca survivors?
Yes. A Cochrane Review found clonidine, selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs),...